CYTRX CORP — Form D/A
CYTRX CORP of LOS ANGELES, CA, a company, filed a Form D amendment with the SEC on 2022-07-28. The offering totals $18.2M, of which $8.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2022-07-28
- Form: D/A
- Accession: 0001493152-22-020517
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $18.2M
- Amount sold: $8.2M
- Remaining: $10.0M
- Investors: 1
- Date of first sale: 2021-07-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-408110
Issuer
- Name: CYTRX CORP
- CIK: 0000799698
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 11726 SAN VICENTE BOULEVARD, LOS ANGELES, CA, 90049
- Phone: (310) 826-5648
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Joel Caldwell | Director | Los Angeles, CA |
| Cary Claiborne | Director | Herzliya, L3 |
| Jennifer Simpson | Director | Raleigh, NC |
| John Caloz | Executive Officer | Los Angeles, CA |
| Stephen Snowdy | Executive Officer | Brookhaven, GA |
| Benjamin Levin | Executive Officer | Norwalk, CT |
| Cheryl Cohen | Director | San Diego, CA |
| Joel J Caldwell | Director | Los Angeles, CA |
| Steven A Kriegsman | Director | Los Angeles, CA |
| Steven A Kriegsman | Executive Officer | Los Angeles, CA |
| Louis J Ignarro | Director | Los Angeles, CA |
| Eric Selter | Director | Los Angeles, CA |
| Anita Chawla | Director | Los Angeles, CA |
| d Haen | Executive Officer | Los Angeles, CA |
| Steven Kreigsman | Director | Los Angeles, AR |
| Steven Kreigsman | Executive Officer | Los Angeles, AR |
| Joseph Rubinfeld | Director | Los Angeles, CA |
| Louis Ignarro | Director | Los Angeles, CA |
Other filings by this issuer (2)
More